Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationDepreciation & Amortization (IS)EBIATLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Shares IssuedShares OutstandingShares Repurchased
Ratios

Xeris Biopharma Holdings (XERS) Long-Term Debt Issuances (2020 - 2024)

Historic Long-Term Debt Issuances for Xeris Biopharma Holdings (XERS) over the last 3 years, with Q1 2024 value amounting to $50.0 million.

  • Xeris Biopharma Holdings' Long-Term Debt Issuances changed N/A to $50.0 million in Q1 2024 from the same period last year, while for Dec 2024 it was $50.0 million, marking a year-over-year change of. This contributed to the annual value of $50.0 million for FY2024, which is N/A changed from last year.
  • Xeris Biopharma Holdings' Long-Term Debt Issuances amounted to $50.0 million in Q1 2024.
  • Xeris Biopharma Holdings' Long-Term Debt Issuances' 5-year high stood at $97.3 million during Q1 2022, with a 5-year trough of $3.5 million in Q4 2020.
  • In the last 3 years, Xeris Biopharma Holdings' Long-Term Debt Issuances had a median value of $49.5 million in 2022 and averaged $49.9 million.